Maravai LifeSciences Holdings Revenue 2019-2023 | MRVI
Maravai LifeSciences Holdings revenue from 2019 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Maravai LifeSciences Holdings Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $289 |
| 2022 | $883 |
| 2021 | $799 |
| 2020 | $284 |
| 2019 | $143 |
| 2018 | $124 |
| Maravai LifeSciences Holdings Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2023-12-31 | $74 |
| 2023-09-30 | $67 |
| 2023-06-30 | $69 |
| 2023-03-31 | $79 |
| 2022-12-31 | $205 |
| 2022-09-30 | $191 |
| 2022-06-30 | $243 |
| 2022-03-31 | $244 |
| 2021-12-31 | $228 |
| 2021-09-30 | $205 |
| 2021-06-30 | $218 |
| 2021-03-31 | $148 |
| 2020-12-31 | $98 |
| 2020-09-30 | $88 |
| 2020-06-30 | $47 |
| 2020-03-31 | $51 |
| 2019-12-31 | |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.906B | $0.289B |
| Maravai LifeSciences Holdings Inc. is a life sciences company providing products for the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company offer products and services in the fields of nucleic acid synthesis, bioprocess impurity detection and analysis, protein labeling and detection to biopharmaceutical, vaccine, diagnostics and cell and gene therapy companies. Maravai LifeSciences Holdings Inc. is based in SAN DIEGO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $185.422B | 24.34 |
| Stryker (SYK) | United States | $128.275B | 31.81 |
| Boston Scientific (BSX) | United States | $107.479B | 34.23 |
| Medtronic (MDT) | Ireland | $105.230B | 14.90 |
| EssilorLuxottica (ESLOY) | France | $98.467B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.075B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.356B | 30.00 |
| ResMed (RMD) | United States | $26.979B | 25.30 |
| Terumo (TRUMY) | Japan | $24.775B | 34.99 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.604B | 15.84 |
| Baxter (BAX) | United States | $20.430B | 14.90 |
| Koninklijke Philips (PHG) | Netherlands | $19.242B | 15.35 |
| Insulet (PODD) | United States | $11.496B | 60.36 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.440B | 0.00 |
| Demant (WILYY) | Denmark | $9.943B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.860B | 23.42 |
| BellRing Brands (BRBR) | United States | $7.238B | 38.92 |
| Lantheus Holdings (LNTH) | United States | $4.470B | 11.54 |
| Haemonetics (HAE) | United States | $4.452B | 22.77 |
| Perrigo (PRGO) | Ireland | $4.238B | 12.12 |
| GN Store Nord (GNNDY) | Denmark | $3.889B | 25.18 |
| Prestige Consumer Healthcare (PBH) | United States | $3.482B | 16.47 |
| Envista Holdings (NVST) | United States | $3.441B | 13.09 |
| QuidelOrtho (QDEL) | United States | $2.654B | 9.63 |
| Neogen (NEOG) | United States | $2.591B | 24.92 |
| Green Thumb Industries (GTBIF) | United States | $2.482B | 78.67 |
| ICU Medical (ICUI) | United States | $2.303B | 17.19 |
| TG Therapeutics (TGTX) | United States | $2.150B | 695.50 |
| Owens & Minor (OMI) | United States | $1.848B | 17.74 |
| Agios Pharmaceuticals (AGIO) | United States | $1.780B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.617B | 0.00 |
| InMode (INMD) | Israel | $1.429B | 7.40 |
| LeMaitre Vascular (LMAT) | United States | $1.414B | 46.66 |
| National Vision Holdings (EYE) | United States | $1.399B | 43.58 |
| AdaptHealth (AHCO) | United States | $1.273B | 9.58 |
| Warby Parker (WRBY) | United States | $1.254B | 0.00 |
| AtriCure (ATRC) | United States | $1.094B | 0.00 |
| MacroGenics (MGNX) | United States | $0.899B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.872B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.764B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.686B | 14.82 |
| Cresco Labs (CRLBF) | United States | $0.674B | 0.00 |
| Evolus (EOLS) | United States | $0.664B | 0.00 |
| Jin Medical (ZJYL) | China | $0.608B | 0.00 |
| Quanterix (QTRX) | United States | $0.596B | 0.00 |
| Valneva SE (VALN) | France | $0.526B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.504B | 10.91 |
| PetIQ (PETQ) | United States | $0.480B | 17.93 |
| TerrAscend (TSNDF) | Canada | $0.462B | 0.00 |
| ZimVie (ZIMV) | United States | $0.421B | 25.80 |
| Biote (BTMD) | United States | $0.416B | 3.96 |
| OraSure Technologies (OSUR) | United States | $0.402B | 6.66 |
| Surmodics (SRDX) | United States | $0.373B | 40.26 |
| Aurora Cannabis (ACB) | Canada | $0.366B | 0.00 |
| Zynex (ZYXI) | United States | $0.352B | 40.52 |
| Viemed Healthcare (VMD) | United States | $0.310B | 30.81 |
| Cerus (CERS) | United States | $0.308B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.278B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.266B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.238B | 14.73 |
| Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.178B | 0.00 |
| Omeros (OMER) | United States | $0.177B | 0.00 |
| Veru (VERU) | United States | $0.177B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.162B | 0.00 |
| High Tide (HITI) | Canada | $0.161B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.156B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.141B | 70.99 |
| FitLife Brands (FTLF) | United States | $0.129B | 20.74 |
| Jushi Holdings (JUSHF) | United States | $0.125B | 0.00 |
| InterCure (INCR) | Israel | $0.120B | 20.31 |
| Fonar (FONR) | United States | $0.107B | 9.16 |
| MariMed (MRMD) | United States | $0.100B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.089B | 0.00 |
| Safety Shot (SHOT) | United States | $0.082B | 0.00 |
| Brainsway (BWAY) | Israel | $0.080B | 0.00 |
| Chimerix (CMRX) | United States | $0.079B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.059B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.055B | 3.59 |
| Apyx Medical (APYX) | United States | $0.051B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 14.95 |
| Bright Green (BGXX) | United States | $0.035B | 0.00 |
| Modular Medical (MODD) | United States | $0.033B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| Flora Growth (FLGC) | United States | $0.020B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.019B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 74.09 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |